Literature DB >> 8562485

Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes.

G Fan1, R Xu, M W Wessendorf, X Ma, B T Kren, C J Steer.   

Abstract

Protein expression of the retinoblastoma (Rb) tumor suppressor gene product was examined by immunoblot analysis of nuclei isolated from regenerating rat liver after 70% partial hepatectomy (PH). Levels were almost undetectable in quiescent 0-h livers but increased 15- to 60-fold 3 to 24 h post-PH, 105-fold at 30 h, and 20- to 50-fold at 60 to 72 h post-PH. Expression returned to near baseline levels at 18, 42, and 48 h post-PH. A similar pattern of Rb protein expression in the regenerating liver was observed by indirect immunofluorescence microscopy, with peak nuclear expression at 30 h post-PH. Rb-related proteins with apparent molecular masses of 300, 156, and 74 kDa were detected in regenerating liver using mAbs to the Rb protein. Their expression increased 6- to 8-fold during regeneration, and only p156 returned to baseline levels at 60 h post-PH. Rb and its related proteins were detected in cultured primary hepatocytes, and although total protein levels did not change appreciably, there was a dramatic shift from cytosol into nuclei through 96 h. The half-life of the Rb protein was determined to be 1.9 h in regenerating liver and 2.2 h in cultured primary hepatocytes. Rb protein abundance in synchronized HuH-7 human hepatoma cells was cell cycle dependent and exhibited peak nuclear expression during S phase. Rb protein was detected primarily in its hyperphosphorylated state during liver regeneration and through the cell cycle of the HuH-7 cells. In vivo administration of transforming growth factor beta 1, an inhibitor of DNA synthesis in regenerating liver, resulted in reduced expression of Rb as well as its protein partners, cell cycle-dependent kinase 4 and cyclin E. The results suggest that in the regenerating rat liver and in synchronized HuH-7 cells, expression of Rb protein is modulated in a cell cycle-dependent fashion, remains primarily in a hyperphosphorylated state, and exhibits a relatively short half-life. The inhibition of Rb protein expression by transforming growth factor beta 1 may be linked to its simultaneous suppression of cell cycle-dependent kinase 4 and cyclin E protein levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562485

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  6 in total

1.  Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1.

Authors:  Kirsten C Sadler; Katherine N Krahn; Naseem A Gaur; Chinweike Ukomadu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

2.  Polysome trafficking of transcripts and microRNAs in regenerating liver after partial hepatectomy.

Authors:  Betsy T Kren; Phillip Y-P Wong; Akira Shiota; Xiaoxiao Zhang; Yan Zeng; Clifford J Steer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

3.  Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control.

Authors:  Christopher A Reed; Christopher N Mayhew; A Kathleen McClendon; Erik S Knudsen
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

4.  After portal branch ligation in the rat, cellular proliferation is associated with selective induction of c-Ha-ras, p53, cyclin E, and Cdk2.

Authors:  P Stärkel; L Lambotte; C Sempoux; C De Saeger; A Saliez; D Maiter; Y Horsmans
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

5.  Met provides essential signals for liver regeneration.

Authors:  Malgorzata Borowiak; Alistair N Garratt; Torsten Wüstefeld; Michael Strehle; Christian Trautwein; Carmen Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

6.  T160‐phosphorylated CDK2 defines threshold for HGF dependent proliferation in primary hepatocytes.

Authors:  Stephanie Mueller; Jérémy Huard; Katharina Waldow; Xiaoyun Huang; Lorenza A D'Alessandro; Sebastian Bohl; Kathleen Börner; Dirk Grimm; Steffen Klamt; Ursula Klingmüller; Marcel Schilling
Journal:  Mol Syst Biol       Date:  2015-03       Impact factor: 11.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.